Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy

Francesca M. Carozzi, Maria L. Tornesello, Elena Burroni, Giovanna Loquercio, Giuseppe Carillo, Claudio Angeloni, Aurora Scalisi, Rosalba Macis, Francesco Chini, Franco M. Buonaguro, Paolo Giorgi Rossi

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Background: The aim of this multicentric study was to identify human papillomavirus (HPV) type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia 2/3 (CIN2/3) in Italy. Methods: Cases were sampled through the electronic databases at the pathology units of eight centers in six regions from central and southern Italy. HPV types were detected from paraffin-embedded tissue samples and cervical specimens through amplification of HPV DNA with GP5+/GP6+ primers, followed by genotyping with reverse line blot (RLB). Untyped HPV-positive samples were sequenced. HPV-negative samples underwent nested PCR, followed by either RLB or sequencing. Finally, the remaining HPV-negative samples were amplified with primers targeting the virus E6 to E7 regions. Results: From 1,162 cases initially selected, 722 samples were further analyzed: 144 CIN2, 385 CIN3, 157 invasive squamous carcinomas, and 36 adenocarcinomas. Samples (6.9%) were HPV negative. The proportion of HPV16/18 was 60.8%, 76.6%, and 78.8% in CIN2, CIN3, and invasive cancers, respectively (P trend = 0.004). There was a significant decreasing trend of HPV16/18 with age in invasive cancers, going from 92% in women 55 years (P = 0.036). The proportion of coinfections was 16.8%, 15.5%, and 10.0% in CIN2, CIN3, and invasive cancers, respectively (P trend = 0.07). Conclusions: The proportion of invasive cancers caused by HPV16/18 decreases with age at diagnosis. Impact: The absolute risk of an invasive cancer due to non-HPV16/18 in women under 35 is extremely low. This finding might prompt us to rise the age at which public HPV screening for vaccinated women should start.

Original languageEnglish
Pages (from-to)2389-2400
Number of pages12
JournalCancer Epidemiology Biomarkers and Prevention
Volume19
Issue number9
DOIs
Publication statusPublished - Sep 2010

Fingerprint

Cervical Intraepithelial Neoplasia
Italy
Neoplasms
Coinfection
Uterine Cervical Neoplasms
Paraffin
Squamous Cell Carcinoma
Adenocarcinoma
Databases
Pathology
Viruses
Polymerase Chain Reaction
DNA

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy. / Carozzi, Francesca M.; Tornesello, Maria L.; Burroni, Elena; Loquercio, Giovanna; Carillo, Giuseppe; Angeloni, Claudio; Scalisi, Aurora; Macis, Rosalba; Chini, Francesco; Buonaguro, Franco M.; Giorgi Rossi, Paolo.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 19, No. 9, 09.2010, p. 2389-2400.

Research output: Contribution to journalArticle

Carozzi, Francesca M. ; Tornesello, Maria L. ; Burroni, Elena ; Loquercio, Giovanna ; Carillo, Giuseppe ; Angeloni, Claudio ; Scalisi, Aurora ; Macis, Rosalba ; Chini, Francesco ; Buonaguro, Franco M. ; Giorgi Rossi, Paolo. / Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy. In: Cancer Epidemiology Biomarkers and Prevention. 2010 ; Vol. 19, No. 9. pp. 2389-2400.
@article{d8853654d2a547a491c18a11185e7bfa,
title = "Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy",
abstract = "Background: The aim of this multicentric study was to identify human papillomavirus (HPV) type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia 2/3 (CIN2/3) in Italy. Methods: Cases were sampled through the electronic databases at the pathology units of eight centers in six regions from central and southern Italy. HPV types were detected from paraffin-embedded tissue samples and cervical specimens through amplification of HPV DNA with GP5+/GP6+ primers, followed by genotyping with reverse line blot (RLB). Untyped HPV-positive samples were sequenced. HPV-negative samples underwent nested PCR, followed by either RLB or sequencing. Finally, the remaining HPV-negative samples were amplified with primers targeting the virus E6 to E7 regions. Results: From 1,162 cases initially selected, 722 samples were further analyzed: 144 CIN2, 385 CIN3, 157 invasive squamous carcinomas, and 36 adenocarcinomas. Samples (6.9{\%}) were HPV negative. The proportion of HPV16/18 was 60.8{\%}, 76.6{\%}, and 78.8{\%} in CIN2, CIN3, and invasive cancers, respectively (P trend = 0.004). There was a significant decreasing trend of HPV16/18 with age in invasive cancers, going from 92{\%} in women 55 years (P = 0.036). The proportion of coinfections was 16.8{\%}, 15.5{\%}, and 10.0{\%} in CIN2, CIN3, and invasive cancers, respectively (P trend = 0.07). Conclusions: The proportion of invasive cancers caused by HPV16/18 decreases with age at diagnosis. Impact: The absolute risk of an invasive cancer due to non-HPV16/18 in women under 35 is extremely low. This finding might prompt us to rise the age at which public HPV screening for vaccinated women should start.",
author = "Carozzi, {Francesca M.} and Tornesello, {Maria L.} and Elena Burroni and Giovanna Loquercio and Giuseppe Carillo and Claudio Angeloni and Aurora Scalisi and Rosalba Macis and Francesco Chini and Buonaguro, {Franco M.} and {Giorgi Rossi}, Paolo",
year = "2010",
month = "9",
doi = "10.1158/1055-9965.EPI-10-0131",
language = "English",
volume = "19",
pages = "2389--2400",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy

AU - Carozzi, Francesca M.

AU - Tornesello, Maria L.

AU - Burroni, Elena

AU - Loquercio, Giovanna

AU - Carillo, Giuseppe

AU - Angeloni, Claudio

AU - Scalisi, Aurora

AU - Macis, Rosalba

AU - Chini, Francesco

AU - Buonaguro, Franco M.

AU - Giorgi Rossi, Paolo

PY - 2010/9

Y1 - 2010/9

N2 - Background: The aim of this multicentric study was to identify human papillomavirus (HPV) type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia 2/3 (CIN2/3) in Italy. Methods: Cases were sampled through the electronic databases at the pathology units of eight centers in six regions from central and southern Italy. HPV types were detected from paraffin-embedded tissue samples and cervical specimens through amplification of HPV DNA with GP5+/GP6+ primers, followed by genotyping with reverse line blot (RLB). Untyped HPV-positive samples were sequenced. HPV-negative samples underwent nested PCR, followed by either RLB or sequencing. Finally, the remaining HPV-negative samples were amplified with primers targeting the virus E6 to E7 regions. Results: From 1,162 cases initially selected, 722 samples were further analyzed: 144 CIN2, 385 CIN3, 157 invasive squamous carcinomas, and 36 adenocarcinomas. Samples (6.9%) were HPV negative. The proportion of HPV16/18 was 60.8%, 76.6%, and 78.8% in CIN2, CIN3, and invasive cancers, respectively (P trend = 0.004). There was a significant decreasing trend of HPV16/18 with age in invasive cancers, going from 92% in women 55 years (P = 0.036). The proportion of coinfections was 16.8%, 15.5%, and 10.0% in CIN2, CIN3, and invasive cancers, respectively (P trend = 0.07). Conclusions: The proportion of invasive cancers caused by HPV16/18 decreases with age at diagnosis. Impact: The absolute risk of an invasive cancer due to non-HPV16/18 in women under 35 is extremely low. This finding might prompt us to rise the age at which public HPV screening for vaccinated women should start.

AB - Background: The aim of this multicentric study was to identify human papillomavirus (HPV) type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia 2/3 (CIN2/3) in Italy. Methods: Cases were sampled through the electronic databases at the pathology units of eight centers in six regions from central and southern Italy. HPV types were detected from paraffin-embedded tissue samples and cervical specimens through amplification of HPV DNA with GP5+/GP6+ primers, followed by genotyping with reverse line blot (RLB). Untyped HPV-positive samples were sequenced. HPV-negative samples underwent nested PCR, followed by either RLB or sequencing. Finally, the remaining HPV-negative samples were amplified with primers targeting the virus E6 to E7 regions. Results: From 1,162 cases initially selected, 722 samples were further analyzed: 144 CIN2, 385 CIN3, 157 invasive squamous carcinomas, and 36 adenocarcinomas. Samples (6.9%) were HPV negative. The proportion of HPV16/18 was 60.8%, 76.6%, and 78.8% in CIN2, CIN3, and invasive cancers, respectively (P trend = 0.004). There was a significant decreasing trend of HPV16/18 with age in invasive cancers, going from 92% in women 55 years (P = 0.036). The proportion of coinfections was 16.8%, 15.5%, and 10.0% in CIN2, CIN3, and invasive cancers, respectively (P trend = 0.07). Conclusions: The proportion of invasive cancers caused by HPV16/18 decreases with age at diagnosis. Impact: The absolute risk of an invasive cancer due to non-HPV16/18 in women under 35 is extremely low. This finding might prompt us to rise the age at which public HPV screening for vaccinated women should start.

UR - http://www.scopus.com/inward/record.url?scp=77956504042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956504042&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-10-0131

DO - 10.1158/1055-9965.EPI-10-0131

M3 - Article

C2 - 20826836

AN - SCOPUS:77956504042

VL - 19

SP - 2389

EP - 2400

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 9

ER -